- Home
- HTFL vs APGE Comparison
HTFL vs APGE Comparison
Compare HTFL & APGE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HTFL
- APGE
- Stock Information
- Founded
- HTFL 2007
- APGE 2022
- Country
- HTFL United States
- APGE United States
- Employees
- HTFL N/A
- APGE N/A
- Industry
- HTFL
- APGE Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- HTFL
- APGE Health Care
- Exchange
- HTFL Nasdaq
- APGE Nasdaq
- Market Cap
- HTFL 2.8B
- APGE 2.4B
- IPO Year
- HTFL 2025
- APGE 2023
- Fundamental
- Price
- HTFL $28.38
- APGE $66.20
- Analyst Decision
- HTFL Strong Buy
- APGE Strong Buy
- Analyst Count
- HTFL 4
- APGE 9
- Target Price
- HTFL $39.50
- APGE $97.33
- AVG Volume (30 Days)
- HTFL 389.4K
- APGE 734.3K
- Earning Date
- HTFL 11-12-2025
- APGE 11-10-2025
- Dividend Yield
- HTFL N/A
- APGE N/A
- EPS Growth
- HTFL N/A
- APGE N/A
- EPS
- HTFL N/A
- APGE N/A
- Revenue
- HTFL $161,881,000.00
- APGE N/A
- Revenue This Year
- HTFL $34.51
- APGE N/A
- Revenue Next Year
- HTFL $24.58
- APGE N/A
- P/E Ratio
- HTFL N/A
- APGE N/A
- Revenue Growth
- HTFL 44.32
- APGE N/A
- 52 Week Low
- HTFL $26.56
- APGE $26.20
- 52 Week High
- HTFL $41.22
- APGE $67.57
- Technical
- Relative Strength Index (RSI)
- HTFL N/A
- APGE 78.13
- Support Level
- HTFL N/A
- APGE $52.34
- Resistance Level
- HTFL N/A
- APGE $64.87
- Average True Range (ATR)
- HTFL 0.00
- APGE 3.32
- MACD
- HTFL 0.00
- APGE 0.55
- Stochastic Oscillator
- HTFL 0.00
- APGE 90.51
About HTFL Heartflow Inc. Common Stock
HeartFlow Inc is a commercial-stage medical technology company that has pioneered the use of software and AI to deliver a non-invasive solution for diagnosing and managing coronary artery disease CAD. The company operates and manages its business as one reportable and operating segment, which is the business of non-invasive coronary artery disease detection solutions. Geographically, it operates in United States, United Kingdom, Japan, and Rest of Europe, of which it derives maximum revenue from United States.
About APGE Apogee Therapeutics Inc.
Apogee Therapeutics Inc is a biotechnology company seeking to develop differentiated biologics for the treatment of atopic dermatitis (AD), chronic obstructive pulmonary disease (COPD), and related inflammatory and immunology (I&I) indications with high unmet need. Its antibody programs are designed to overcome the limitations of existing therapies by targeting well-established mechanisms of action and incorporating antibody engineering to optimize half-life and other properties.